Cell BiologybioRxivPreprint
A cell-based, spike protein binding assay highlights differences in antibody neutralising capacity for SARS-CoV-2 variants
N. Harrison, L. Richardson, C. Pallini…·O. S. Qureshi
The paper develops a cell-based ACE2/spike protein binding assay to assess antibody neutralising capacity against SARS-CoV-2 variants and shows differential blocking activity of monoclonal antibodies.
DOI 10.1101/2022.06.24.496409